-
1
-
-
0034727073
-
Immune control of HIV-1 after early treatment of acute infection
-
Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-526.
-
(2000)
Nature
, vol.407
, pp. 523-526
-
-
Rosenberg, E.S.1
Altfeld, M.2
Poon, S.H.3
-
2
-
-
0034711393
-
Control of SIV rebound through structured treatment interruptions during early infection
-
Lori F, Lewis MG, Xu J, et al. Control of SIV rebound through structured treatment interruptions during early infection. Science 2000; 290:1591-1593.
-
(2000)
Science
, vol.290
, pp. 1591-1593
-
-
Lori, F.1
Lewis, M.G.2
Xu, J.3
-
3
-
-
0028909872
-
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
-
Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-579.
-
(1995)
Ann Intern Med
, vol.122
, pp. 573-579
-
-
Mellors, J.W.1
Kingsley, L.A.2
Rinaldo Jr, C.R.3
-
4
-
-
0030070991
-
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
-
Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170.
-
(1996)
Science
, vol.272
, pp. 1167-1170
-
-
Mellors, J.W.1
Rinaldo Jr, C.R.2
Gupta, P.3
-
5
-
-
0037007670
-
HIV preferentially infects HIV-specific CD4+ T cells
-
Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417:95-98.
-
(2002)
Nature
, vol.417
, pp. 95-98
-
-
Douek, D.C.1
Brenchley, J.M.2
Betts, M.R.3
-
6
-
-
15744361847
-
Limited durability of viral control following treated acute HIV infection
-
Kaufmann DE, Lichterfeld M, Altfeld M, et al. Limited durability of viral control following treated acute HIV infection. PLoS Med 2004; 1:e36.
-
(2004)
PLoS Med
, vol.1
-
-
Kaufmann, D.E.1
Lichterfeld, M.2
Altfeld, M.3
-
7
-
-
0036720475
-
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination
-
Markowitz M, Jin X, Hurley A, et al. Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J Infect Dis 2002; 186:634-643.
-
(2002)
J Infect Dis
, vol.186
, pp. 634-643
-
-
Markowitz, M.1
Jin, X.2
Hurley, A.3
-
8
-
-
33748428894
-
-
Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006; 194:725-733. This study of a large number of individuals identified during acute infection shows a significant, although limited, benefit of the treatment of acute HIV infection on the viral load and CD4 T-cell count.
-
Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006; 194:725-733. This study of a large number of individuals identified during acute infection shows a significant, although limited, benefit of the treatment of acute HIV infection on the viral load and CD4 T-cell count.
-
-
-
-
9
-
-
33748433647
-
-
Streeck H, Jessen H, Alter G, et al. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. J Infect Dis 2006; 194:734-739. This study of subjects diagnosed during acute HIV that either underwent HIV therapy or stayed without treatment does not show a benefit of early treatment in terms of viral load and CD4 cell count once therapy is interrupted.
-
Streeck H, Jessen H, Alter G, et al. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. J Infect Dis 2006; 194:734-739. This study of subjects diagnosed during acute HIV that either underwent HIV therapy or stayed without treatment does not show a benefit of early treatment in terms of viral load and CD4 cell count once therapy is interrupted.
-
-
-
-
10
-
-
17844374605
-
-
Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-1097. This study demonstrates the massive destruction of CD4 memory T cells in the lymphoid tissue through direct viral infection during acute retroviral infection.
-
Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-1097. This study demonstrates the massive destruction of CD4 memory T cells in the lymphoid tissue through direct viral infection during acute retroviral infection.
-
-
-
-
11
-
-
17844376742
-
-
Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434:1148-1152. This report demonstrates the infection of resting memory CD4 T cells in mucosal tissues, and provides data supporting the concept of the destruction of CD4 T cells by both direct infection and apoptosis of uninfected cells.
-
Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434:1148-1152. This report demonstrates the infection of resting memory CD4 T cells in mucosal tissues, and provides data supporting the concept of the destruction of CD4 T cells by both direct infection and apoptosis of uninfected cells.
-
-
-
-
12
-
-
27644513772
-
-
Beignon AS, McKenna K, Skoberne M, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 115:3265-3275. This study demonstrates that HIV-1 RNA can directly activate plasmacytoid dendritic cells through interaction with Toll-like receptors.
-
Beignon AS, McKenna K, Skoberne M, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 115:3265-3275. This study demonstrates that HIV-1 RNA can directly activate plasmacytoid dendritic cells through interaction with Toll-like receptors.
-
-
-
-
13
-
-
21644488003
-
-
Reynolds MR, Rakasz E, Skinner PJ, et al. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J Virol 2005; 79:9228-9235. This study demonstrates that antiviral CTL responses appear after the extensive destruction of CD4 T cells in the lymphoid tissue.
-
Reynolds MR, Rakasz E, Skinner PJ, et al. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J Virol 2005; 79:9228-9235. This study demonstrates that antiviral CTL responses appear after the extensive destruction of CD4 T cells in the lymphoid tissue.
-
-
-
-
14
-
-
0032540418
-
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
-
Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280:427-431.
-
(1998)
Science
, vol.280
, pp. 427-431
-
-
Veazey, R.S.1
DeMaria, M.2
Chalifoux, L.V.3
-
15
-
-
0031903088
-
Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection
-
Mattapallil JJ, Smit-McBride Z, McChesney M, Dandekar S. Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection. J Virol 1998; 72:6421-6429.
-
(1998)
J Virol
, vol.72
, pp. 6421-6429
-
-
Mattapallil, J.J.1
Smit-McBride, Z.2
McChesney, M.3
Dandekar, S.4
-
16
-
-
4644342929
-
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
-
Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
-
(2004)
J Exp Med
, vol.200
, pp. 749-759
-
-
Brenchley, J.M.1
Schacker, T.W.2
Ruff, L.E.3
-
17
-
-
0142092389
-
Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
-
Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-11717.
-
(2003)
J Virol
, vol.77
, pp. 11708-11717
-
-
Guadalupe, M.1
Reay, E.2
Sankaran, S.3
-
18
-
-
4644289983
-
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
-
Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:761-770.
-
(2004)
J Exp Med
, vol.200
, pp. 761-770
-
-
Mehandru, S.1
Poles, M.A.2
Tenner-Racz, K.3
-
19
-
-
0033524838
-
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
-
Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:857-860.
-
(1999)
Science
, vol.283
, pp. 857-860
-
-
Schmitz, J.E.1
Kuroda, M.J.2
Santra, S.3
-
20
-
-
0033559648
-
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
-
Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999; 189:991-998.
-
(1999)
J Exp Med
, vol.189
, pp. 991-998
-
-
Jin, X.1
Bauer, D.E.2
Tuttleton, S.E.3
-
21
-
-
0028337166
-
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
-
Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-4655.
-
(1994)
J Virol
, vol.68
, pp. 4650-4655
-
-
Koup, R.A.1
Safrit, J.T.2
Cao, Y.3
-
22
-
-
0028041344
-
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
-
Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68:6103-6110.
-
(1994)
J Virol
, vol.68
, pp. 6103-6110
-
-
Borrow, P.1
Lewicki, H.2
Hahn, B.H.3
-
23
-
-
0037432736
-
Immunology CD8 T cells remember with a little help
-
Kaech SM, Ahmed R. Immunology CD8 T cells remember with a little help. Science 2003; 300:263-265.
-
(2003)
Science
, vol.300
, pp. 263-265
-
-
Kaech, S.M.1
Ahmed, R.2
-
24
-
-
0037103201
-
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection
-
Harari A, Rizzardi GP, Ellefsen K, et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002; 100:1381-1387.
-
(2002)
Blood
, vol.100
, pp. 1381-1387
-
-
Harari, A.1
Rizzardi, G.P.2
Ellefsen, K.3
-
25
-
-
23944431912
-
-
Zaunders J, Munier ML, Kaufmann DE, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection. Blood 2005; 106:1660-1667. This study provides a detailed functional and phenotypic characterization of HIV-specific CD4 T cells during acute HIV infection.
-
Zaunders J, Munier ML, Kaufmann DE, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection. Blood 2005; 106:1660-1667. This study provides a detailed functional and phenotypic characterization of HIV-specific CD4 T cells during acute HIV infection.
-
-
-
-
26
-
-
11844306664
-
-
Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005; 174:1037-1045. This paper demonstrated that the functional heterogeneity in terms of cytokine secretion of antigen-specific CD4 T cells correlates with antigen load and persistence.
-
Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005; 174:1037-1045. This paper demonstrated that the functional heterogeneity in terms of cytokine secretion of antigen-specific CD4 T cells correlates with antigen load and persistence.
-
-
-
-
27
-
-
0347382593
-
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells
-
Kaech SM, Tan JT, Wherry EJ, et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-1198.
-
(2003)
Nat Immunol
, vol.4
, pp. 1191-1198
-
-
Kaech, S.M.1
Tan, J.T.2
Wherry, E.J.3
-
28
-
-
0035923542
-
High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation
-
McNeil AC, Shupert WL, Iyasere CA, et al. High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation. Proc Natl Acad Sci U S A 2001; 98:13878-13883.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 13878-13883
-
-
McNeil, A.C.1
Shupert, W.L.2
Iyasere, C.A.3
-
29
-
-
0141677716
-
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2
-
Iyasere CA, Tilton JC, Johnson AJ, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 2003; 77:10900-10909.
-
(2003)
J Virol
, vol.77
, pp. 10900-10909
-
-
Iyasere, C.A.1
Tilton, J.C.2
Johnson, A.J.3
-
30
-
-
0347911962
-
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity
-
Younes SA, Yassine-Diab B, Dumont AR, et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003; 198:1909-1922.
-
(2003)
J Exp Med
, vol.198
, pp. 1909-1922
-
-
Younes, S.A.1
Yassine-Diab, B.2
Dumont, A.R.3
-
31
-
-
0036192919
-
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy
-
Rizzardi GP, Harari A, Capiluppi B, et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest 2002; 109:681-688.
-
(2002)
J Clin Invest
, vol.109
, pp. 681-688
-
-
Rizzardi, G.P.1
Harari, A.2
Capiluppi, B.3
-
32
-
-
0038205695
-
Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection
-
Alter G, Hatzakis G, Tsoukas CM, et al. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol 2003; 171:477-488.
-
(2003)
J Immunol
, vol.171
, pp. 477-488
-
-
Alter, G.1
Hatzakis, G.2
Tsoukas, C.M.3
-
33
-
-
0035862330
-
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
-
Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169-180.
-
(2001)
J Exp Med
, vol.193
, pp. 169-180
-
-
Altfeld, M.1
Rosenberg, E.S.2
Shankarappa, R.3
-
34
-
-
0032728214
-
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection
-
Dalod M, Dupuis M, Deschemin JC, et al. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. J Clin Invest 1999; 104:1431-1439.
-
(1999)
J Clin Invest
, vol.104
, pp. 1431-1439
-
-
Dalod, M.1
Dupuis, M.2
Deschemin, J.C.3
-
35
-
-
4644249757
-
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells
-
Lichterfeld M, Kaufmann DE, Yu XG, et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 2004; 200:701-712.
-
(2004)
J Exp Med
, vol.200
, pp. 701-712
-
-
Lichterfeld, M.1
Kaufmann, D.E.2
Yu, X.G.3
-
36
-
-
23044447269
-
-
Jansen CA, De Cuyper IM, Steingrover R, et al. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. AIDS 2005; 19:1145-1154. This report shows that the augmentation of HIV-specific CD4 T-cell responses after the treatment of acute HIV infection did not correlate with enhanced viral control after treatment interruption.
-
Jansen CA, De Cuyper IM, Steingrover R, et al. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. AIDS 2005; 19:1145-1154. This report shows that the augmentation of HIV-specific CD4 T-cell responses after the treatment of acute HIV infection did not correlate with enhanced viral control after treatment interruption.
-
-
-
-
37
-
-
32644442808
-
-
Jansen CA, De Cuyper IM, Hooibrink B, et al. Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study. Blood 2006; 107:1427-1433. This large cohort study demonstrates that the magnitude HIV-specific CD4 T-cell responses assessed by cytokine secretion and proliferation assays early after acute HIV infection were not predictive of disease progression.
-
Jansen CA, De Cuyper IM, Hooibrink B, et al. Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study. Blood 2006; 107:1427-1433. This large cohort study demonstrates that the magnitude HIV-specific CD4 T-cell responses assessed by cytokine secretion and proliferation assays early after acute HIV infection were not predictive of disease progression.
-
-
-
-
38
-
-
27744561661
-
-
Seth N, Kaufmann D, Lahey T, et al. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol 2005; 175:6948-6958. A detailed characterization of HIV-specific CD4 T-cell responses after acute infection using class II tetramers.
-
Seth N, Kaufmann D, Lahey T, et al. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol 2005; 175:6948-6958. A detailed characterization of HIV-specific CD4 T-cell responses after acute infection using class II tetramers.
-
-
-
-
39
-
-
0036852179
-
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors
-
Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-1068.
-
(2002)
Nat Immunol
, vol.3
, pp. 1061-1068
-
-
Migueles, S.A.1
Laborico, A.C.2
Shupert, W.L.3
-
41
-
-
4043060710
-
Correlates of immune protection in HIV-1 infection: What we know, what we don't know, what we should know
-
Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 2004; 10:806-810.
-
(2004)
Nat Med
, vol.10
, pp. 806-810
-
-
Pantaleo, G.1
Koup, R.A.2
-
42
-
-
1642500367
-
Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: Changes after antiretroviral therapy
-
Harari A, Petitpierre S, Vallelian F, Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004; 103:966-972.
-
(2004)
Blood
, vol.103
, pp. 966-972
-
-
Harari, A.1
Petitpierre, S.2
Vallelian, F.3
Pantaleo, G.4
-
43
-
-
20144384850
-
-
Betts MR, Exley B, Price DA, et al. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci U S A 2005; 102:4512-4517. This report investigates the changes in the characteristics of the HIV-specific T cells in a vaccinated subject who subsequently became infected by HIV.
-
Betts MR, Exley B, Price DA, et al. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci U S A 2005; 102:4512-4517. This report investigates the changes in the characteristics of the HIV-specific T cells in a vaccinated subject who subsequently became infected by HIV.
-
-
-
-
44
-
-
23244463710
-
-
Kinloch-de Loes S, Hoen B, Smith DE, et al. Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. J Infect Dis 2005; 192:607-617. This study describes the lack of effect of an adjuvant immunotherapy in treated acute HIV infection (QUEST study).
-
Kinloch-de Loes S, Hoen B, Smith DE, et al. Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. J Infect Dis 2005; 192:607-617. This study describes the lack of effect of an adjuvant immunotherapy in treated acute HIV infection (QUEST study).
-
-
-
-
45
-
-
33744990609
-
-
Letvin NL, Mascola JR, Sun Y, et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006; 312:1530-1533. This study demonstrates that vaccine-generated pre-existing SIV-specific immunity can improve survival after SIV infection, and that this benefit correlates with the preservation of the central memory CD4 T-cell count and with vaccine-induced CD4 and CD8 T-cell responses in peripheral blood.
-
Letvin NL, Mascola JR, Sun Y, et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006; 312:1530-1533. This study demonstrates that vaccine-generated pre-existing SIV-specific immunity can improve survival after SIV infection, and that this benefit correlates with the preservation of the central memory CD4 T-cell count and with vaccine-induced CD4 and CD8 T-cell responses in peripheral blood.
-
-
-
-
46
-
-
33745015013
-
-
Mattapallil JJ, Douek DC, Buckler-White A, et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J Exp Med 2006; 203:1533-1541. This report shows that vaccine-generated pre-existing simian immunodeficiency virus-specific immunity can improve survival after simian immunodeficiency virus infection and that this benefit correlates with the preservation of the central memory CD4 T-cell population in various lymphoid tissues and with vaccine-induced CD4 and CD8 T-cell responses.
-
Mattapallil JJ, Douek DC, Buckler-White A, et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J Exp Med 2006; 203:1533-1541. This report shows that vaccine-generated pre-existing simian immunodeficiency virus-specific immunity can improve survival after simian immunodeficiency virus infection and that this benefit correlates with the preservation of the central memory CD4 T-cell population in various lymphoid tissues and with vaccine-induced CD4 and CD8 T-cell responses.
-
-
-
|